Impact of rebate contract legislation on generic substitution of valproate – a retrospective study of ambulatory drug dispensing in the DAPI database

Katrin Schüssel, Sittah Czeche, Katrin Kuhn & Martin Schulz
Introduction: Generic substitution of antiepileptic drugs is controversially discussed, and rebate contracts between pharmaceutical manufacturers and statutory health insurance funds (SHI) may have increased the problem. The aim of this study was to quantify generic switching in patients treated with[for full text, please go to the a.m. URL]